Clinical trials: Acute-on-Chronic Liver Failure (ACLF)
- Condition Acute-on-Chronic Liver Failure (ACLF)
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Acute-on-Chronic Liver Failure
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects
- Trial name
- NCT07110441
- Testing
- Single Dose G1090N, Multiple dosing of G1090N
- Where
- United States
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- Genfit